Old Web
English
Sign In
Acemap
>
authorDetail
>
Asha Nayak-Kapoor
Asha Nayak-Kapoor
Medicine
Cancer research
Pathology
Internal medicine
Cancer
4
Papers
78
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Phase 2 trial of the IDO pathway inhibitor indoximod plus gemcitabine / nab-paclitaxel for the treatment of patients with metastatic pancreas cancer.
2018
Journal of Clinical Oncology
Nathan Bahary
Andrea Wang-Gillam
Sigurdis Haraldsdottir
Bradley G. Somer
Jin S. Lee
Mark Allen O'Rourke
Asha Nayak-Kapoor
Gregory L. Beatty
Mingen Liu
Devora Delman
Gabriela R. Rossi
Eugene P. Kennedy
Nicholas N. Vahanian
Charles J. Link
Ignacio Garrido–Laguna
Show All
Source
Cite
Save
Citations (20)
Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors
2018
Journal for ImmunoTherapy of Cancer
Asha Nayak-Kapoor
Zhonglin Hao
Ramses F. Sadek
Robin Dobbins
Lisa Marshall
Nicholas N. Vahanian
W. Jay Ramsey
Eugene P. Kennedy
Mario Mautino
Charles J. Link
Ray Lin
Stephanie Royer-Joo
Xiaorong Liang
Laurent Salphati
Kari Morrissey
Sami Mahrus
Bruce McCall
Andrea Pirzkall
David H. Munn
John E. Janik
Samir N. Khleif
Show All
Source
Cite
Save
Citations (58)
Vitamin D levels and its relationship with successful completion of adjuvant chemotherapy and improved survival in early stage colorectal cancer patients.
2017
Journal of Clinical Oncology
Khurram Bilal Tariq
Aaron Gopal
Asha Nayak-Kapoor
Show All
Source
Cite
Save
Citations (0)
Chromogranin A levels to predict survival in resectable pancreatic neuroendocrine tumors.
2017
Journal of Clinical Oncology
Khurram Bilal Tariq
Brandon Roberts
Asha Nayak-Kapoor
Show All
Source
Cite
Save
Citations (0)
1